Aurisco Pharmaceutical Co., Ltd. (605116) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Aurisco Pharmaceutical Co., Ltd.

Why is Aurisco Pharmaceutical Co., Ltd. ?

Negative results in Sep 25

INTEREST(HY) At CNY 17.36 MM has Grown at 210.44%
INVENTORY TURNOVER RATIO(HY) Lowest at 1.1 times
DEBTORS TURNOVER RATIO(HY) Lowest at 4.24 times

With ROE of 16.35%, it has a fair valuation with a 3.73 Price to Book Value

Over the past year, while the stock has generated a return of 25.25%, its profits have risen by 4.6% ; the PEG ratio of the company is 5
At the current price, the company has a high dividend yield of 1.3

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Aurisco Pharmaceutical Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Aurisco Pharmaceutical Co., Ltd.

-6.57%

0.41

32.50%

China Shanghai Composite

21.43%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

19.05%

EBIT Growth (5y)

24.09%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

0.01

Sales to Capital Employed (avg)

0.49

Tax Ratio

12.85%

Dividend Payout Ratio

30.55%

Pledged Shares

Institutional Holding

ROCE (avg)

17.19%

ROE (avg)

13.03%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.83

EV to EBIT

16.21

EV to EBITDA

13.38

EV to Capital Employed

2.76

EV to Sales

4.63

PEG Ratio

19.76

Dividend Yield

1.49%

ROCE (Latest)

17.02%

ROE (Latest)

14.31%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 492.42 MM

-21What is not working for the Company

INTEREST(9M)

At CNY 27.21 MM has Grown at 18.71%

ROCE(HY)

Lowest at 15.26%

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.1 times

INTEREST COVERAGE RATIO(Q)

Lowest at 966.02

RAW MATERIAL COST(Y)

Grown by 9.34% (YoY

DEBT-EQUITY RATIO (HY)

Highest at 4.81 %

NET SALES(Q)

Lowest at CNY 389.26 MM

OPERATING PROFIT(Q)

Lowest at CNY 88.49 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 22.73 %

PRE-TAX PROFIT(Q)

Lowest at CNY 74.54 MM

NET PROFIT(Q)

Lowest at CNY 61.77 MM

EPS(Q)

Lowest at CNY 0.16

Here's what is working for Aurisco Pharmaceutical Co., Ltd.

Operating Cash Flow

Highest at CNY 492.42 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Here's what is not working for Aurisco Pharmaceutical Co., Ltd.

Interest

At CNY 27.21 MM has Grown at 18.71%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 966.02

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Pre-Tax Profit

At CNY 74.54 MM has Fallen at -46.74%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 61.77 MM has Fallen at -47.68%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Debtors Turnover Ratio

Lowest at 4.1 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Net Sales

Lowest at CNY 389.26 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 88.49 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 22.73 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CNY 74.54 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY 61.77 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY 0.16

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Debt-Equity Ratio

Highest at 4.81 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost

Grown by 9.34% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales